Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Perineuronal Net Degradation Drives Social Memory Loss in AD
2026-05-27
The referenced study demonstrates that degradation of perineuronal nets (PNNs) in the hippocampal CA2 region directly underlies social memory impairment in Alzheimer’s disease (AD) mouse models. Chronic inhibition of matrix metalloproteinases (MMPs) preserved PNNs and delayed social cognitive decline, highlighting PNN integrity as a promising target for therapeutic intervention in AD.
-
Eicosapentaenoic Acid: Protocol Innovations for Cardiovascul
2026-05-27
Eicosapentaenoic Acid (EPA) from APExBIO sets new standards for cardiovascular and immunometabolic research through high-purity, workflow-ready formulations. This guide reveals actionable protocol enhancements, troubleshooting tactics, and insights drawn from cross-domain immune modulation studies.
-
RNA Pol II Inhibition: Apoptosis Is Triggered by Pol IIA Los
2026-05-26
Harper et al. (2025) demonstrate that inhibition of RNA polymerase II activates a regulated, mitochondria-mediated apoptotic response through the loss of hypophosphorylated Pol IIA, rather than simple mRNA decay. This discovery reframes our understanding of cell death in response to transcriptional stress, offering new mechanistic insights for DNA damage response and cancer biology research.
-
Optimizing Apoptosis Detection with One-step TUNEL Cy3 Kit (
2026-05-26
This evidence-based guide explores practical laboratory challenges in apoptosis detection and demonstrates how the One-step TUNEL Cy3 Apoptosis Detection Kit (SKU K1134) streamlines DNA fragmentation assays. By integrating scenario-driven Q&A, best practices, and peer-reviewed data, researchers can achieve reproducible, sensitive results in both tissue sections and cultured cells.
-
SIRT3-SUMO Regulation of Treg Differentiation in Asthma via
2026-05-25
This study uncovers a mechanistic link between SIRT3-SUMO regulation and Treg cell differentiation in asthma by mediating N-glycosylation through the fatty acid oxidation (FAO) pathway. The findings highlight new metabolic and post-translational control points in immune regulation that may inform targeted asthma therapies.
-
Anti-ROR1 Antibody (Zilovertamab): Transforming Toxicology a
2026-05-25
Discover how Anti-ROR1 Antibody (Zilovertamab) revolutionizes Wnt5a-induced ROR1 signaling inhibition and functional assays in toxicology and oncology. Explore unique protocol insights, mechanistic context, and advanced applications for cancer and liver injury models.
-
Lysoptosis: A Conserved Serpin-Regulated Cell Death Pathway
2026-05-24
The referenced study defines lysoptosis as a distinct, evolutionarily conserved lysosome-dependent cell death pathway controlled by intracellular serpins. By demonstrating the central role of lysosomal membrane permeabilization and cathepsin activity across species, the research clarifies mechanistic boundaries within regulated cell death and provides a robust model for dissecting cysteine protease function in both physiological and pathological contexts.
-
Harnessing Advanced TUNEL-Cy3 Detection for Translational Ap
2026-05-23
Explore how the One-step TUNEL Cy3 Apoptosis Detection Kit empowers translational researchers to dissect apoptosis and cell death mechanisms with unprecedented sensitivity, precision, and workflow efficiency. This article connects molecular insight, validated protocols, and strategic guidance for oncology and cell biology frontiers, including lessons from recent breakthroughs in pyroptosis.
-
TCAIM-Mediated Regulation of OGDH Protein and Mitochondrial
2026-05-22
The reference study uncovers a novel post-translational mechanism by which the mitochondrial DNAJC co-chaperone TCAIM specifically reduces a-ketoglutarate dehydrogenase (OGDH) protein levels, thereby modulating mitochondrial metabolism. This work challenges classical views of chaperone function and highlights new avenues for metabolic research and potential therapeutic strategies.
-
STING Agonist-1: Optimizing STING Pathway Activation in Immu
2026-05-22
STING agonist-1 empowers researchers to dissect innate immune mechanisms and B cell-driven antitumor responses with reproducible, high-purity activation of the STING pathway. This practical guide translates recent breakthroughs in tertiary lymphoid structure biology into actionable workflows, troubleshooting strategies, and advanced applications using this robust immunology research reagent.
-
Vancomycin Hydrochloride: Advanced Controls for Tissue Engin
2026-05-21
Explore how Vancomycin hydrochloride, a glycopeptide antibacterial agent, underpins high-precision controls in tissue engineering, infection modeling, and antibiotic resistance assays. This article reveals new insights beyond standard microbiological protocols, integrating cutting-edge findings from regenerative medicine.
-
Sildenafil Citrate: Advanced Workflows for PDE5 Inhibitor Re
2026-05-21
Sildenafil Citrate drives reproducible, proteoform-specific insights in vascular and pulmonary research. Unlock data-rich workflows, troubleshoot pitfalls, and leverage the latest native MS findings for precision cGMP pathway modulation.
-
Next-Gen mRNA Capping: ARCA’s Impact on Translational Resear
2026-05-20
Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G is redefining mRNA capping for translational science. This article unpacks the mechanistic rationale, evidence from hiPSC-to-oligodendrocyte reprogramming, and actionable guidance for maximizing translational output, while offering a strategic perspective beyond conventional product reviews.
-
Selective SGLT2 Inhibitors and Cardioprotection: Insights fr
2026-05-20
This article details a pivotal study comparing the cardioprotective effects of selective SGLT2 inhibitors—including Ertugliflozin (PF-04971729)—in a non-diabetic mouse model of myocardial ischemia/reperfusion (I/R) injury. The findings reveal that not all SGLT2 inhibitors confer equal cardioprotection at standard dosing, highlighting the importance of mechanistic pathways beyond glucose reabsorption.
-
MRSA: Molecular Mechanisms, Epidemiology, and Research Advan
2026-05-19
The reference review synthesizes decades of basic and clinical research on methicillin-resistant Staphylococcus aureus (MRSA), clarifying the genetic, molecular, and epidemiological factors underlying its emergence and persistence. These insights inform laboratory modeling strategies and underscore the ongoing challenges in treating MRSA infections.